- Home
- LTH vs INM Comparison
LTH vs INM Comparison
Compare LTH & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTH
- INM
- Stock Information
- Founded
- LTH 1992
- INM 1981
- Country
- LTH United States
- INM Canada
- Employees
- LTH N/A
- INM N/A
- Industry
- LTH Hotels/Resorts
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- LTH Consumer Discretionary
- INM Health Care
- Exchange
- LTH Nasdaq
- INM Nasdaq
- Market Cap
- LTH 5.5B
- INM 5.0M
- IPO Year
- LTH 2021
- INM N/A
- Fundamental
- Price
- LTH $26.00
- INM $2.02
- Analyst Decision
- LTH Buy
- INM
- Analyst Count
- LTH 12
- INM 0
- Target Price
- LTH $36.54
- INM N/A
- AVG Volume (30 Days)
- LTH 2.0M
- INM 110.3K
- Earning Date
- LTH 11-04-2025
- INM 11-13-2025
- Dividend Yield
- LTH N/A
- INM N/A
- EPS Growth
- LTH 93.31
- INM N/A
- EPS
- LTH 1.03
- INM N/A
- Revenue
- LTH $2,824,027,000.00
- INM $4,942,633.00
- Revenue This Year
- LTH $14.65
- INM N/A
- Revenue Next Year
- LTH $11.15
- INM N/A
- P/E Ratio
- LTH $25.49
- INM N/A
- Revenue Growth
- LTH 17.25
- INM 7.50
- 52 Week Low
- LTH $21.49
- INM $1.72
- 52 Week High
- LTH $34.99
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- LTH 43.20
- INM 40.61
- Support Level
- LTH $25.50
- INM $2.04
- Resistance Level
- LTH $26.19
- INM $2.26
- Average True Range (ATR)
- LTH 0.67
- INM 0.13
- MACD
- LTH 0.03
- INM -0.01
- Stochastic Oscillator
- LTH 44.09
- INM 0.00
About LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.